Why the study?
Do nurse-led intervention management programmes improve heart failure knowledge, self-care management, and health-related quality of life in patients with heart failure?
Do nurse-led intervention management programmes improve heart failure knowledge, self-care management, and health-related quality of life in patients with heart failure?
Answers are grounded in this paper and cite their sources.
Nurse-led interventions, including telephone support and in-person education, improve self-care and physical quality of life in heart failure patients, underscoring the need for standardized reporting and context-specific care models.
This invited commentary refers to ‘Effectiveness of a multicentre randomized controlled trial with three different nurse-led intervention management programmes for patients with heart failure: the main results of the MEETinCY study’, by E. Lambrinou et al., https://doi.org/10.1093/eurjcn/zvae169. Over recent decades, nurse-led clinics have improved the management of cardiovascular disease (CVD) and in particular the outcomes of patients and their families living with heart failure.1 Seminal clinical trials have laid the foundation for the critical importance of the role of nurses in heart failure management.2 Heart failure disease management programmes prevent hospitalizations, decrease symptoms, improve quality of life, and decrease mortality for patients with heart failure. In this commentary, we seek to emphasize the importance of accurate and transparent reporting of models of care, specific interventions, the need to describe the comparator arms in detail as well as the context and setting of the study.3 Suggestions for advancing nurse-led clinical trial research are also provided. Systematic reviews of nurse-led clinics in a range of CVD conditions, including hypertension and atrial fibrillation, provide information on the efficacy and outcomes of nurse-led models, yet, also shine a light on the diversity and heterogeneity of models, dosing of interventions, and outcome measures.4,5 Commentary on systematic reviews of nurse led models have noted a range of limitations including publication bias with the majority of studies reporting positive outcomes and the bulk of articles published in English limiting a diverse cultural understanding and understanding of implementation across a range of health systems. Moreover, variability in the intensity, frequency, and duration of interventions makes comparisons across studies difficult and head-to-head studies are challenging and expensive.6 As we look to implementing evidence from clinical trials, the importance and value of consistent nomenclature and a standardized taxonomy is critically important. Although statistical methods can account for heterogeneity and reduce bias in meta-analyses in systematic reviews, standardizing reporting is important in both implementation and advancing the science. For example, the CONSORT statement guides describing clinical trial design and methods, including interventions, in sufficient detail to enable replication7 but does not always include description of funding and scope of practice. Adding the TIDieR checklist is a useful tool in ensuring intervention fidelity and providing sufficient information to allow replication and implementation.8 In the European Journal of Cardiovascular Nursing, Lambrinou et al.9 report the findings of a single-blinded, multi-centred randomized controlled trial examining the effectiveness of a nurse-led, 3-month telephone follow-up, a telephone follow-up with education before discharge, or education only before discharge, on the heart failure knowledge, self-care management and health-related quality of life of study participants. This is the first randomized controlled trial in nurse-led management of heart failure in the Republic of Cyprus laying the foundations for not only improving culturally appropriate and contextually specific care but also fostering nurse-led research. As the importance of nurse-led models increases it is important to understand the structure and dynamics of these interventions within contemporaneous health systems. Within the context of implementation and as heart failure management evolves, understanding usual care, which is commonly the control condition in clinical trials, is also important. A nurse-led intervention involves nurses taking control of a specific dimension of patient care.10 Internationally, there is considerable variation in the structure of nurse-led clinics, the scope of nursing practice, and funding models across healthcare systems. Variability in the dosing (intensity, frequency, and duration) of interventions is important to consider when appraising the nature of nursing interventions. Appreciating conceptual underpinnings and differentiating key concepts and relationships among expert clinical assessment, nursing intervention components, and patient engagement and activation is important in formulating interventions. In the Lambrinou et al.9 study, the intervention was informed by self-care principles and needs assessment. Both of these theoretical perspectives have a rich and deep history in nursing science. The intervention also involved a bibliographic dimension, which is important to consider in replication of the intervention. In this study, telephone support for self-care management appeared to impact the physical dimension of health-related quality of life but not the emotional and social dimensions of assessment. This underscores the importance of tailoring and targeting specific elements in the intervention and elements of focus are largely driven by conceptual underpinnings.11 Perhaps one of the greatest challenges in undertaking an evaluation of trials of nurse-led clinics is describing and understanding usual care and isolating the impact of the intervention from other health and social care interventions. Usual care is the ‘routine’ care provided to patients. As the importance of self-management and coordinated care is emphasized in clinical practice guidelines, understanding this status of guideline adoption is important. Over two decades ago, Moser and Mann wrote ‘Improving Outcomes in Heart Failure: It’s Not Unusual Beyond Usual Care’.12 In current practice, shared decision-making, patient education, and self-management support should be standardized elements of HF management; therefore, explaining the usual care condition is increasingly important when undertaking research on models of care.13 As we focus more on the social determinants of health in heart failure management, there is also an increasing importance of understanding context and setting as findings may not be transferrable to other healthcare systems, particularly where nurses have varying scopes of practice, capabilities, and access to resources.14 Moreover, as models of care become increasingly person-centered, sharing the best available evidence and recognizing the needs, values, and preferences of patients and their families when faced with the task of making decisions is central yet highly variable. When considering description of usual care, it is also important to consider the involvement of patients and their families, physicians, and other providers in developing interventions, delivering health care, and how nurses are configured in the healthcare team. This study provides some useful insights into the delivery of nurse-led care. There was an improvement in the physical dimension of the health-related quality of life (F = 2.7, df = 3, P = 0.046) between the control group and in person education group.9 The telephone component alone or in combination with the in-person education led to greater improvement in self-care (F = 3, df = 3, P = 0.034) and both arms were superior to the control group (P = 0.002).9 This suggests some flexibility in the mode of elements of nurse-led heart failure care. The investigators also identified that older people were unable to be recruited for the study and the challenges of health literacy, emphasizing the importance of tailored recruitment processes. Understanding the operational context, such as staffing levels, collaboration with physicians, or integration into existing healthcare systems, is important in interpreting findings and assessing the capacity for replication, scale, and sustainability. Embedding strategies to avoid loss to follow-up is also an important focus to improve the integrity of the clinical trial and to assess acceptability. The advancement of nursing science and practice has led to an increasing number of studies of nurse-led clinics. It goes without saying that nurses need to conduct adequately powered, randomized controlled trials in diverse HF populations and healthcare settings. To date, many studies focus on short-term rather than long-term outcomes. The shortage of funding can limit design and length of follow-up. Limited evidence on the sustainability and long-term impact of nurse-led clinics on patient or healthcare system outcomes is not available, which can challenge long-term funding. In the available literature, there is limited information on how to address barriers to adherence, particularly for socioeconomic or cultural factors. As we focus on greater personalization of care, understanding which patients benefit most from nurse-led interventions and require specific focus is also important. The one-size-fits-all approach is not aligned with an emphasis on person-centred care. Since the first clinical trials of nurse-led clinics in heart failure much has changed both in the complexity of clinical management, including increasing technology, and rising awareness of health inequity. As we look to the future with the aging of the population and increasing multimorbidity nurse-led and coordinated interventions will be critical. Recognizing the phenomenon of temporality, which is the changes in patient clinical status, preferences, and needs over time, and an evolving illness trajectory will be needed. Therefore, including reporting of implementation context in clinical trials will be critical. A plethora of guidelines and systematic reviews demonstrate the importance of disease management in HF. The greatest challenge is to make sure these interventions are widely accessible, delivered with fidelity, of high value and are cost-effective. Krumholz and colleagues have provided a taxonomy for disease management. This approach is highly useful in describing interventions from the perspective of provider and recipient in relation to dosing, timing, mode, and setting.15 There is also an increasing emphasis on multilevel and multicomponent interventions to promote health equity. Measuring the effects of multilevel and/or multicomponent interventions on outcomes is challenging because this will allow interaction among levels; yet, the impact of each intervention must be assessed and evaluated carefully with the context for translation into practice. The Central Illustration provides recommendations for reporting of nurse-led clinical trials to both assist in design, analysis, reporting, and implementation. As heart failure management progresses, applying co-design methods to ensure interventions are person-centred, accessible, equitable and contemporaneous will be increasingly important.16,17Articulating the nurses’ role in the context of increasing adoption of technology and telehealth will be needed in developing models of care. As both the intricacy of heart failure management increases and sociodemographic profiles evolve, addressing not only the validity, reliability, and applicability of clinical trials methods will be required but also understanding contextual factors of health systems and the role and scope of nursing practice. We need to ensure our description of nurse-led interventions clearly articulates the nurses’ position in the healthcare team, their scope of practice; the conceptual underpinnings of design elements, mode and dosing of delivery; and conveys how these models are positioned within the healthcare system. Patricia M. Davidson [PhD RN (Conceptualization: Lead; Writing—original draft: Lead; Writing—review & editing: Lead)], Binu Koirala [PhD RN (Writing—review & editing: Equal)], and Cheryl R. Himmelfarb [PhD RN (Conceptualization: Equal; Writing—review & editing: Equal)] No external funding obtained. No primary data related to this commentary.
No takes yet. Share an insight, caveat, or question.
Davidson et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: